Enzymatically modified isoquercitrin, formerly known as EMIQ, is a flavonoid. EMIQ is a mixture of quercetin monoglucoside and its alpha-oligoglucosides that has been shown to have significantly greater bioavailability than other available forms. In animals, EMIQ was shown to produce a 40 fold increase in Cmax (peak plasma concentration) and an 18-fold increase in the area under the curve compared to quercetin. In humans, EMIQ supplementation increased plasma concentrations to a significantly greater degree than other forms,3 including aglycone and isoquercitrin, with randomized placebo-controlled trials documenting improvement in allergic symptoms. EMIQ has also shown significantly enhanced biological activity especially in animal models of allergy and neoplasia.

纯度：≥98%

CAS：482-35-9